Terms: = Cervical cancer AND BRAF, MGC126806, 673, ENSG00000157764, MGC138284, RAFB1, P15056, B-raf 1, BRAF1, B-raf1 AND Prognosis
30 results:
1. Clinical and molecular features of progressive papillary thyroid microcarcinoma.
Wang Z; Ji X; Zhang H; Sun W
Int J Surg; 2024 Apr; 110(4):2313-2322. PubMed ID: 38241301
[TBL] [Abstract] [Full Text] [Related]
2. Risk factors for central lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study.
Du J; Yang Q; Sun Y; Shi P; Xu H; Chen X; Dong T; Shi W; Wang Y; Song Z; Shang X; Tian X
Front Endocrinol (Lausanne); 2023; 14():1288527. PubMed ID: 38047112
[TBL] [Abstract] [Full Text] [Related]
3. Advances in the management of anaplastic thyroid carcinoma: transforming a life-threatening condition into a potentially treatable disease.
Califano I; Smulever A; Jerkovich F; Pitoia F
Rev Endocr Metab Disord; 2024 Feb; 25(1):123-147. PubMed ID: 37648897
[TBL] [Abstract] [Full Text] [Related]
4. Predictive factors for nodal recurrence in differentiated thyroid cancers.
Kaur J; Nadarajan A; Janardhan D; George NA; Thomas S; Varghese BT; Krishna J
Cancer Treat Res Commun; 2023; 36():100728. PubMed ID: 37336036
[TBL] [Abstract] [Full Text] [Related]
5. Impact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic Thyroid Carcinoma.
Wang JR; Montierth M; Xu L; Goswami M; Zhao X; Cote G; Wang W; Iyer P; Dadu R; Busaidy NL; Lai SY; Gross ND; Ferrarotto R; Lu C; Gunn GB; Williams MD; Routbort M; Zafereo ME; Cabanillas ME
JCO Precis Oncol; 2022 Aug; 6():e2100504. PubMed ID: 35977347
[TBL] [Abstract] [Full Text] [Related]
6. Conventional papillary thyroid carcinoma with intraglandular lymphatic dissemination shows more aggressive features.
Lei Y; Feng S; Yu Q; Shen G; Yuan L; Huang W
Jpn J Clin Oncol; 2022 Nov; 52(11):1311-1320. PubMed ID: 35863013
[TBL] [Abstract] [Full Text] [Related]
7. Survival impact of additional chemotherapy after adjuvant concurrent chemoradiation in patients with early cervical cancer who underwent radical hysterectomy.
Kim SI; Kim JY; Wee CW; Lee M; Kim HS; Chung HH; Lee TS; Jeon HW; Park NH; Song YS; Kim TH
BMC Cancer; 2021 Nov; 21(1):1260. PubMed ID: 34809599
[TBL] [Abstract] [Full Text] [Related]
8. A prediction model incorporating the braf
Liu S; Liu C; Zhao L; Wang K; Li S; Tian Y; Jiao B; Gui Z; Yu T; Zhang L
Eur J Surg Oncol; 2021 Nov; 47(11):2774-2780. PubMed ID: 34483032
[TBL] [Abstract] [Full Text] [Related]
9. A case report of simultaneous medullary and papillary carcinoma of thyroid.
Ziaolhagh R; Sadrizadeh A; Shabany BP; Roudi AA
Endocr Regul; 2021 May; 55(2):83-88. PubMed ID: 34020529
[No Abstract] [Full Text] [Related]
10. [Hobnail variant of papillary thyroid carcinoma].
Da Cruz V; Lopez J; Lifante JC; Decaussin-Petrucci M
Ann Pathol; 2021 Apr; 41(2):201-206. PubMed ID: 33272718
[TBL] [Abstract] [Full Text] [Related]
11. Dynamic analysis of circulating tumor DNA to predict prognosis and monitor therapeutic response in metastatic relapsed cervical cancer.
Tian X; Ge D; Zhang F; Zhang B; Bai W; Xu X; Li Z; Cao Y; Li P; Zou K; Zou L
Int J Cancer; 2021 Feb; 148(4):921-931. PubMed ID: 33113150
[TBL] [Abstract] [Full Text] [Related]
12. Treatment of consistent braf/HRAS gene mutation and MYC amplification radiation-induced abdominal wall angiosarcoma with low-dose apatinib: a case report.
Guan J; Luo Z; Xiao Z; Xie Y; Lin L
BMC Cancer; 2019 Dec; 19(1):1188. PubMed ID: 31805975
[TBL] [Abstract] [Full Text] [Related]
13. The prognostic landscape of tumor-infiltrating immune cells in cervical cancer.
Wang J; Li Z; Gao A; Wen Q; Sun Y
Biomed Pharmacother; 2019 Dec; 120():109444. PubMed ID: 31562978
[TBL] [Abstract] [Full Text] [Related]
14. High expression of survivin predicts poor prognosis in cervical squamous cell carcinoma treated with paclitaxel and carboplatin.
Zhang Y; Yan H; Li R; Guo Y; Zheng R
Medicine (Baltimore); 2019 May; 98(20):e15607. PubMed ID: 31096466
[TBL] [Abstract] [Full Text] [Related]
15. Impact of tumor-associated macrophages and braf
Cho JW; Kim WW; Lee YM; Jeon MJ; Kim WG; Song DE; Park Y; Chung KW; Hong SJ; Sung TY
Head Neck; 2019 Mar; 41(3):686-691. PubMed ID: 30659691
[TBL] [Abstract] [Full Text] [Related]
16. braf
Li J; Liu J; Yu X; Bao X; Qian L
Pathol Res Pract; 2018 Nov; 214(11):1892-1897. PubMed ID: 30270103
[TBL] [Abstract] [Full Text] [Related]
17. Does diabetes mellitus have an impact on the prognosis for patients with cervical cancer?
In Choi J; Chang HK; Lee DW; Lee KH; Park JS; Lee HN
Gynecol Oncol; 2015 Nov; 139(2):319-23. PubMed ID: 26360017
[TBL] [Abstract] [Full Text] [Related]
18. Designing a high-throughput somatic mutation profiling panel specifically for gynaecological cancers.
Spaans VM; Trietsch MD; Crobach S; Stelloo E; Kremer D; Osse EM; Haar NT; van Eijk R; Muller S; van Wezel T; Trimbos JB; Bosse T; Smit VT; Fleuren GJ
PLoS One; 2014; 9(3):e93451. PubMed ID: 24671188
[TBL] [Abstract] [Full Text] [Related]
19. [Melanomas of the female genital tract: state of the art].
Trone JC; Guy JB; Mery B; Langrand Escure J; Lahmar R; Moncharmont C; Rivoirard R; Semay T; Chauleur C; Collard O; Vignot S; Magné N
Bull Cancer; 2014 Jan; 101(1):102-6. PubMed ID: 24445910
[TBL] [Abstract] [Full Text] [Related]
20. braf mutation in papillary thyroid carcinoma: predictive value for long-term prognosis and radioiodine sensitivity.
Zoghlami A; Roussel F; Sabourin JC; Kuhn JM; Marie JP; Dehesdin D; Choussy O
Eur Ann Otorhinolaryngol Head Neck Dis; 2014 Feb; 131(1):7-13. PubMed ID: 23845288
[TBL] [Abstract] [Full Text] [Related]
[Next]
